NK cells and NKT cells in innate defense against viral infections

被引:347
作者
Biron, CA [1 ]
Brossay, L [1 ]
机构
[1] Brown Univ, Dept Mol Microbiol & Immunol, Div Biol & Med, Providence, RI 02912 USA
关键词
D O I
10.1016/S0952-7915(00)00241-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
NK cells contribute to innate defense during certain viral infections, but the mechanisms for their regulation and delivery of antiviral effects are incompletely understood. A second NK cell population, from within T cell populations - NKT cells - has a unique potential to initiate cellular effector mechanisms, including those delivered by NK cells, provided that the antigen for their restricted TCR is induced during infection. If elicited, particular innate cytokine responses promote activation of NK cell cytotoxicity or IFN-gamma production. These responses can contribute to defense by mediating antiviral and/or immunoregulatory effects. Roles of positive or negative receptors for target cells in protection against viruses are less clear. Exciting new data indicate that, in at least one system, NK cell receptors that positively signal for activation participate in the recruitment of these cells into antiviral defense mechanisms. Other recent evidence suggests that NKT cells may be important for protection during one viral infection and may be artificially activated by delivery of antigen to promote antiviral defense. Taken together, these recent advances in the characterization of the NK and NKT cell responses are filling in the details of the complex and critical events taking place, at the earliest times after challenge, to promote resistance to viruses.
引用
收藏
页码:458 / 464
页数:7
相关论文
共 55 条
[1]   NK1.1+ cells and murine cytomegalovirus infection:: What happens in situ? [J].
Andrews, DM ;
Farrell, HE ;
Densley, EH ;
Scalzo, AA ;
Shellam, GR ;
Degli-Esposti, MA .
JOURNAL OF IMMUNOLOGY, 2001, 166 (03) :1796-1802
[2]   Mouse CD1-specific NK1 T cells: Development, specificity, and function [J].
Bendelac, A ;
Rivera, MN ;
Park, SH ;
Roark, JH .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :535-562
[3]   In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers [J].
Benlagha, K ;
Weiss, A ;
Beavis, A ;
Teyton, L ;
Bendelac, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (11) :1895-1903
[4]   Natural killer cells in antiviral defense: Function and regulation by innate cytokines [J].
Biron, CA ;
Nguyen, KB ;
Pien, GC ;
Cousens, LP ;
Salazar-Mather, TP .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :189-220
[5]  
BIRON CA, 2001, IN PRESS IMMUNITY IN
[6]   Human natural killer cells produce abundant macrophage inflammatory protein-1 in response to monocyte-derived cytokines [J].
Bluman, EM ;
Bartynski, KJ ;
Avalos, BR ;
Caligiuri, MA .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (12) :2722-2727
[7]   HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C [J].
Braud, VM ;
Allan, DSJ ;
O'Callaghan, CA ;
Söderström, K ;
D'Andrea, A ;
Ogg, GS ;
Lazetic, S ;
Young, NT ;
Bell, JI ;
Phillips, JH ;
Lanier, LL ;
McMichael, AJ .
NATURE, 1998, 391 (6669) :795-799
[8]   CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution [J].
Brossay, L ;
Chioda, M ;
Burdin, N ;
Koezuka, Y ;
Casorati, G ;
Dellabona, P ;
Kronenberg, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (08) :1521-1528
[9]   Vital involvement of a natural killer cell activation receptor in resistance to viral infection [J].
Brown, MG ;
Dokun, AO ;
Heusel, JW ;
Smith, HRC ;
Beckman, DL ;
Blattenberger, EA ;
Dubbelde, CE ;
Stone, LR ;
Scalzo, AA ;
Yokoyama, WM .
SCIENCE, 2001, 292 (5518) :934-937
[10]  
Burdin N, 1999, EUR J IMMUNOL, V29, P2014, DOI 10.1002/(SICI)1521-4141(199906)29:06<2014::AID-IMMU2014>3.0.CO